MichaelDavidCraigMD

Clinical Trials

• Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29

  Active, not recruiting

  Phase 3

• Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation Start of enrollment: 2010 Oct 12

  Completed

  Phase 2

• Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP) Start of enrollment: 2010 Sep 01

  Completed

• Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08

  Active, not recruiting

  Phase 2

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

• Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash Start of enrollment: 2012 Feb 01

  Completed

  Phase 2

• Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation Start of enrollment: 2014 Jan 20

  Completed

  Phase 2

• Effect of Body Mass on Filgrastim Pharmacokinetics Start of enrollment: 2012 Dec 05

  Completed

• A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12

  Completed

  Phase 2

• Unrelated Umbilical Cord Blood (UBC)Transplantation Start of enrollment: 2009 Feb 03

  Completed

  Not Applicable

• Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09

  Active, not recruiting

  Phase 3

• Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04

  Active, not recruiting

  Phase 3

• Join now to see all